ARCHIVES

FDA Approves Votrient For Renal Cell Carcinoma

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

ASCO Releases Abstracts To 25,000, But Adds Warning On Stock Trading

April 19, 2002

Sanofi: Zaltrap Price Reflects Competing Drugs In Second-Line Metastatic Colon Cancer

November 1, 2012

ACS Awards Grants To Wisconsin, USC For Behavior Research

July 16, 1993

NCI Progress: Biomarker Labratories Funded To Develop Early Detection Methods

October 22, 1999

NCI Begins Ovarian Cancer Trial To Build Blood Samples

October 28, 2005

Magnson Makes It Clear Senate Will Add Substantial Sums To Budget, Objects To Training Grant Phaseout

May 17, 1974